60 Participants Needed

tDCS + Cognitive Training for Post-Stroke Cognitive Impairment

(TIPSCI Trial)

EB
Overseen ByElisabeth B Marsh, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The investigators will conduct a randomized, double-blinded, sham-controlled trial of approximately 60 patients with minor stroke and post-stroke mild cognitive impairment (psMCI). Participants will be individually randomized on enrollment using a random number generator to treatment with anodal tDCS + computerized cognitive treatment (CCT) versus sham + CCT (approximately 30 patients in each arm). Clinical evaluation including assessment of cognition will be performed pre- and post-intervention by individuals on the study team blinded to the participant's intervention. Participants will also undergo functional neuroimaging with magnetoencephalography (MEG) pre- and post-intervention (1, 3, and 6 months post-stroke to evaluate for initial and longer-term effects of treatment on cerebral activation patterns and functional connectivity). Neuroimaging and clinical outcomes will be assessed to determine the effect of tDCS versus sham + CCT on psMCI.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is the treatment Anodal transcranial Direct Current Stimulation (A-tDCS) combined with cognitive training effective for improving cognitive function in post-stroke patients?

Research shows that combining transcranial direct current stimulation (tDCS) with cognitive training can improve cognitive performance during the stimulation in healthy individuals, but the benefits do not necessarily lead to long-term learning improvements. In stroke patients, while cognitive training alone showed significant improvements, adding tDCS did not provide additional benefits.12345

Is transcranial direct current stimulation (tDCS) safe for humans?

Transcranial direct current stimulation (tDCS) is generally considered safe for humans, with studies showing no serious adverse effects in over 33,200 sessions across various populations, including potentially vulnerable groups. However, some reports suggest it could potentially cause significant conditions in healthy individuals, so caution is advised.46789

How does the treatment Anodal tDCS differ from other treatments for post-stroke cognitive impairment?

Anodal tDCS is a non-invasive brain stimulation technique that uses a mild electrical current to enhance cognitive function, which is different from traditional drug-based treatments. It is often combined with cognitive training to potentially improve cognitive performance, although its effects can be less predictable and vary among individuals.35101112

Research Team

EB

Elisabeth B Marsh, MD

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for adults over 18 who've had a minor stroke within the last week and show mild cognitive issues afterward. They must speak English, have manageable stroke symptoms (NIHSS <8), and be relatively independent (mRS 0-2). People with dementia, severe psychiatric illness, or those unable to attend sessions are excluded.

Inclusion Criteria

Your stroke severity score is less than 8 at your first follow-up visit, which is about 30 days after the stroke.
I am an adult who had stroke symptoms start within the last week.
You have recently had a stroke shown on a brain MRI. Strokes that don't show up on imaging and transient ischemic attacks (TIAs) will also be excluded.
See 2 more

Exclusion Criteria

You have bleeding in your brain as shown by a head CT or MRI.
I have hearing or vision problems that haven't been corrected.
I have a major blood vessel blockage near my heart or brain.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 15 sessions of anodal tDCS or sham intervention over 5 weeks, combined with computerized cognitive therapy (CCT)

5 weeks
15 sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with MEG and cognitive assessments at 1, 3, and 6 months post-stroke

6 months
3 visits (in-person)

Treatment Details

Interventions

  • Anodal transcranial Direct Current Stimulation (A-tDCS)
  • Sham Intervention
Trial OverviewThe study tests if anodal transcranial Direct Current Stimulation (A-tDCS) combined with computerized cognitive treatment improves cognition in post-stroke patients compared to a sham intervention. It's randomized and double-blinded, meaning participants won't know which treatment they're getting.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: A-tDCSExperimental Treatment1 Intervention
Participants randomized to tDCS will undergo 15- 30 minute sessions over 5 weeks of A-tDCS to the ipsilesional frontoparietal cortex while participating in computerized cognitive therapy (CCT).
Group II: Sham InterventionActive Control1 Intervention
Participants randomized to sham will undergo 15- 30 minute sessions over 5 weeks of a sham-intervention, also applied to the ipsilesional frontoparietal cortex, while participating in computerized cognitive therapy (CCT).

Anodal transcranial Direct Current Stimulation (A-tDCS) is already approved in United States, European Union, China for the following indications:

🇺🇸
Approved in United States as Transcranial Direct Current Stimulation for:
  • Post-stroke cognitive impairment
  • Post-stroke depression
  • Aphasia
  • Central post-stroke pain
🇪🇺
Approved in European Union as Transcranial Direct Current Stimulation for:
  • Post-stroke cognitive impairment
  • Post-stroke depression
  • Aphasia
  • Central post-stroke pain
🇨🇳
Approved in China as Transcranial Direct Current Stimulation for:
  • Post-stroke cognitive impairment
  • Post-stroke depression
  • Aphasia
  • Central post-stroke pain

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

University of Maryland, College Park

Collaborator

Trials
163
Recruited
46,800+

Findings from Research

In a study involving 11 newly diagnosed stroke patients, the combination of transcranial direct current stimulation (tDCS) and computer-assisted cognitive rehabilitation (CACR) significantly improved cognitive function compared to a control group receiving sham stimulation.
Patients receiving tDCS showed notable enhancements in auditory and visual continuous performance tests, suggesting that targeting the prefrontal cortex with tDCS alongside cognitive training can effectively aid recovery from cognitive dysfunction after a stroke.
A double-blind, sham-controlled, pilot study to assess the effects of the concomitant use of transcranial direct current stimulation with the computer assisted cognitive rehabilitation to the prefrontal cortex on cognitive functions in patients with stroke.Park, SH., Koh, EJ., Choi, HY., et al.[2022]
In a study of 45 stroke patients with cognitive dysfunction, anodal transcranial direct-current stimulation (tDCS) applied to the left anterior temporal lobe significantly improved verbal learning abilities compared to sham stimulation.
Despite improvements in verbal learning, there were no significant changes in overall cognitive function or daily living activities as measured by the K-MMSE and K-MBI, suggesting that tDCS may specifically enhance certain cognitive aspects rather than overall cognitive performance.
The Effects of Transcranial Direct-Current Stimulation on Cognition in Stroke Patients.Yun, GJ., Chun, MH., Kim, BR.[2020]
Transcranial direct current stimulation (tDCS) combined with cognitive training significantly improved executive function and performance in daily activities among 50 stroke patients, as measured by various cognitive tests.
While most cognitive assessments showed significant improvements in the tDCS group compared to the sham group, some specific tasks related to daily living did not show notable differences, indicating that tDCS may be more effective for certain cognitive functions than others.
Explore combined use of transcranial direct current stimulation and cognitive training on executive function after stroke.Liu, YW., Chen, ZH., Luo, J., et al.[2022]

References

A double-blind, sham-controlled, pilot study to assess the effects of the concomitant use of transcranial direct current stimulation with the computer assisted cognitive rehabilitation to the prefrontal cortex on cognitive functions in patients with stroke. [2022]
The Effects of Transcranial Direct-Current Stimulation on Cognition in Stroke Patients. [2020]
Explore combined use of transcranial direct current stimulation and cognitive training on executive function after stroke. [2022]
Can transcranial direct current stimulation enhance outcomes from cognitive training? A randomized controlled trial in healthy participants. [2022]
Reliability, sensitivity, and predictive value of fMRI during multiple object tracking as a marker of cognitive training gain in combination with tDCS in stroke survivors. [2022]
Enhancing Immediate Memory, Potential Learning, and Working Memory with Transcranial Direct Current Stimulation in Healthy Older Adults. [2023]
A Systematic Review on the Acceptability and Tolerability of Transcranial Direct Current Stimulation Treatment in Neuropsychiatry Trials. [2018]
Safety of transcranial direct current stimulation in healthy participants. [2021]
Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. [2022]
Modulation of Repeated Anodal HD-tDCS on Attention in Healthy Young Adults. [2020]
The effectiveness of anodal tDCS and cognitive training on cognitive functions in multiple sclerosis; a randomized, double-blind, parallel-group study. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Cognitive Effects of Transcranial Direct Current Stimulation in Healthy and Clinical Populations: An Overview. [2019]